Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.005 USD | +3.32% | +5.32% | -24.14% |
05-10 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
05-09 | Health Catalyst Seeks M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.14% | 400M | |
-18.88% | 217B | |
-7.94% | 66.67B | |
-1.55% | 56.89B | |
-9.54% | 47.11B | |
-0.03% | 39.63B | |
-5.99% | 34.12B | |
-9.41% | 28.8B | |
+110.16% | 27.66B | |
+5.25% | 22.01B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Raymond James Adjusts Health Catalyst's Price Target to $15 From $20, Keeps Strong Buy Rating